Hologicvs.Natera
HOLX vs NTRA · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Natera is about 2.3× larger than Hologic by market cap; year to date, Natera leads (+17.8% vs +2.0%).
Side by side
| HOLX | NTRA | |
|---|---|---|
| Market cap | $17B | $38.8B |
| Price | — | $269.95 |
| Today | — | −4.2% |
| Return YTD | +2.0% | +17.8% |
| Return 1Y | −3.5% | +65.2% |
| P/E | 31.2 | — |
| P/S | 4.1 | 15.5 |
| P/B | 3.2 | 21.9 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
HologicHOLX
American medical technology company focused on women's health — diagnostics, mammography (imaging) and surgery.
Full HOLX profile →NateraNTRA
Molecular and genetic diagnostics across prenatal screening, oncology and transplantation.
Full NTRA profile →More comparisons in Diagnostics
See where HOLX and NTRA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →